SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
7.14
+0.52 (7.85%)
At close: Nov 6, 2026, 4:00 PM EST
7.28
+0.14 (1.96%)
After-hours: Nov 6, 2026, 7:38 PM EST
SOPHiA GENETICS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 90.97 | 77.27 | 65.17 | 62.37 | 47.56 | 40.45 | |
Revenue Growth | 24.11% | 18.56% | 4.49% | 31.14% | 17.58% | 42.43% |
Cost of Revenue | 30.54 | 25.19 | 21.24 | 19.46 | 16.31 | 15.23 |
Gross Profit | 60.44 | 52.08 | 43.94 | 42.91 | 31.25 | 25.22 |
Selling, General & Admin | 99.08 | 88.68 | 76.32 | 81.72 | 84.08 | 70.24 |
Research & Development | 35.02 | 34.22 | 34.37 | 36.97 | 35.37 | 26.58 |
Other Operating Expenses | 0.04 | 0.11 | -0.18 | -0.98 | -0.45 | -0.16 |
Operating Expenses | 134.14 | 123.01 | 110.51 | 117.71 | 119 | 96.66 |
Operating Income | -73.7 | -70.93 | -66.57 | -74.8 | -87.75 | -71.44 |
Interest Expense | -6.58 | -4.55 | -1.91 | -0.59 | -0.64 | -0.66 |
Interest & Investment Income | 1.35 | 1.87 | 3.36 | 4.55 | 1.32 | 0.02 |
Currency Exchange Gain (Loss) | -0.52 | -3.4 | 3.48 | -7.63 | -0.45 | -1.38 |
Other Non Operating Income (Expenses) | -1.46 | -0.5 | 0.37 | - | - | - |
EBT Excluding Unusual Items | -80.91 | -77.52 | -61.27 | -78.47 | -87.51 | -73.46 |
Gain (Loss) on Sale of Assets | 0.03 | 0.03 | - | -0.03 | - | -0.02 |
Asset Writedown | - | - | - | - | -0.07 | -0.03 |
Pretax Income | -80.88 | -77.49 | -61.27 | -78.5 | -87.59 | -73.51 |
Income Tax Expense | 0.25 | 1.51 | 1.22 | 0.49 | -0.14 | 0.17 |
Net Income | -81.13 | -79 | -62.49 | -78.98 | -87.45 | -73.68 |
Net Income to Common | -81.13 | -79 | -62.49 | -78.98 | -87.45 | -73.68 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 75 | 68 | 66 | 65 | 64 | 55 |
Shares Outstanding (Diluted) | 75 | 68 | 66 | 65 | 64 | 55 |
Shares Change | 11.27% | 2.24% | 2.02% | 1.02% | 15.91% | 30.58% |
EPS (Basic) | -1.09 | -1.17 | -0.95 | -1.22 | -1.36 | -1.33 |
EPS (Diluted) | -1.09 | -1.17 | -0.95 | -1.22 | -1.36 | -1.33 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -41.52 | -36.47 | -44.76 | -54.72 | -74.19 | -60.62 |
Free Cash Flow Per Share | -0.56 | -0.54 | -0.68 | -0.84 | -1.16 | -1.10 |
Gross Margin | 66.43% | 67.40% | 67.42% | 68.80% | 65.72% | 62.35% |
Operating Margin | -81.02% | -91.80% | -102.14% | -119.92% | -184.50% | -176.61% |
Profit Margin | -89.18% | -102.24% | -95.89% | -126.63% | -183.87% | -182.14% |
Free Cash Flow Margin | -45.64% | -47.19% | -68.68% | -87.73% | -155.99% | -149.87% |
EBITDA | -71.69 | -69.17 | -64.59 | -69.29 | -83.96 | -67.83 |
EBITDA Margin | -78.80% | -89.51% | -99.11% | -111.09% | -176.53% | -167.68% |
D&A For EBITDA | 2.02 | 1.77 | 1.98 | 5.51 | 3.79 | 3.61 |
EBIT | -73.7 | -70.93 | -66.57 | -74.8 | -87.75 | -71.44 |
EBIT Margin | -81.02% | -91.80% | -102.14% | -119.92% | -184.50% | -176.61% |